A public meeting on drug repurposing is held at 10:30 a.m. ET on Aug. 4 to examine considerations for selecting and prioritizing new uses for FDA-approved drugs. Hosted by the Reagan-Udall Foundation for the FDA, the meeting brings together representatives from federal agencies, clinicians, researchers, and patient organization...








